TSS
KZIA

Two Sigma Securities’s Kazia Therapeutics KZIA Stock Holding History

Two Sigma Securities’s Portfolio KZIA Stock Details KZIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-368
Closed -$5.71K – 3357
2024
Q1 		$5.71K Sell
368
-800
-68% -$12K ﹤0.01% 2823
2023
Q4 		$25.7K Buy
+1,168
New +$34.2K ﹤0.01% 2687
2023
Q1 		– Sell
-245
Closed -$7.52K – 2993
2022
Q4 		$7.52K Buy
245
+10
+4% +$376 ﹤0.01% 2402
2022
Q3 		$13K Sell
235
-260
-53% -$29.1K ﹤0.01% 2358
2022
Q2 		$104K Buy
+495
New +$152K ﹤0.01% 1746

Other funds holding KZIA

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
AF
Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return
AF
Advisornet Financial Minnetonka, Minnesota $2.19B AUM 21.28% 1-Year Est. Return

Two Sigma Securities's KZIA Position: Q2 2024 in Review

Two Sigma Securities sold out of Kazia Therapeutics (KZIA) in Q2 2024, closing a stake of 368 shares — an estimated $5.71K sold.

Two Sigma Securities first reported a position in KZIA in Q2 2022 and held it in 5 quarters. The position peaked at $104K in Q2 2022. 9 funds tracked by Wall St. Rank hold KZIA as of Q2 2024.

  • Two Sigma Securities reported no remaining Kazia Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Two Sigma Securities sold 368 Kazia Therapeutics shares in Q2 2024, an estimated $5.71K.
  • Two Sigma Securities first reported a position in Kazia Therapeutics in Q2 2022 and held it in 5 quarters.
  • Two Sigma Securities's Kazia Therapeutics position peaked at $104K in Q2 2022.
  • 9 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q2 2024.

Based on Two Sigma Securities's 13F filing for Q2 2024, filed 14 Aug 2024.